MIRA Pharmaceuticals Achieves 100% Reversal Of Neuropathic Pain With Oral Ketamir-2 In A Rat Study, Outperforming Oral Ketamine And Showcasing Its Potential As A Significant Treatment For Neuropathic Pain, Setting The Stage For Further Clinical Trials.
MIRA Pharmaceuticals Achieves 100% Reversal Of Neuropathic Pain With Oral Ketamir-2 In A Rat Study, Outperforming Oral Ketamine And Showcasing Its Potential As A Significant Treatment For Neuropathic Pain, Setting The Stage For Further Clinical Trials.
米拉制藥在大鼠研究中使用口服Ketamir-2成功實現了100%的神經病理性疼痛逆轉，勝過了口服氯胺酮，並展示了其作爲神經病理性疼痛重要治療的潛力，爲進一步的臨床試驗鋪平了道路。
MIRA Pharmaceuticals Achieves 100% Reversal Of Neuropathic Pain With Oral Ketamir-2 In A Rat Study, Outperforming Oral Ketamine And Showcasing Its Potential As A Significant Treatment For Neuropathic Pain, Setting The Stage For Further Clinical Trials.
米拉制藥在大鼠研究中使用口服Ketamir-2成功實現了100%的神經病理性疼痛逆轉，勝過了口服氯胺酮，並展示了其作爲神經病理性疼痛重要治療的潛力，爲進一步的臨床試驗鋪平了道路。